The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.